|
[1]
|
Banerjee A, Mossman K, Grandvaux N. Molecular determinants of SARS-CoV-2 variants. Trends Microbiol 2021;29(10):871 − 3. http://dx.doi.org/10.1016/j.tim.2021.07.002CrossRef
|
|
[2]
|
Turakhia Y, Thornlow B, Hinrichs A, McBroome J, Ayala N, Ye C, et al. Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape. Nature 2022;609(7929):994 − 7. http://dx.doi.org/10.1038/s41586-022-05189-9CrossRef
|
|
[3]
|
Arora P, Zhang L, Rocha C, Graichen L, Nehlmeier I, Kempf A, et al. The SARS-CoV-2 delta-omicron recombinant lineage (XD) exhibits immune-escape properties similar to the omicron (BA. 1) variant. Int J Mol Sci 2022;23(22):14057. http://dx.doi.org/10.3390/ijms232214057CrossRef
|
|
[4]
|
Hotez P. XBB. 1.5 emerges in the Americas: what it means to the region. Lancet Reg Health Am 2023;18:100433. http://dx.doi.org/10.1016/j.lana.2023.100433CrossRef
|
|
[5]
|
Wang SW, Niu PH, Su QD, He XZ, Tang J, Wand J, et al. Genomic surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023. China CDC Wkly 2023;5(7):143 − 51. http://dx.doi.org/10.46234/ccdcw2023.026CrossRef
|
|
[6]
|
Su K, Huang Y, Chen XF, Liu FY, Yan Q, Jiang XY, et al. The first case of co-infection with omicron subvariants BA.5.2.48 and BF.7.14 — Chongqing Municipality, China, February 2023. China CDC Wkly 2023;5(11):255-7. http://dx.doi.org/10.46234/ccdcw2023.046.http://dx.doi.org/10.46234/ccdcw2023.046 |
|
[7]
|
Shu YL, McCauley J. GISAID: global initiative on sharing all influenza data - from vision to reality. Euro Surveill 2017;22(13):30494. http://dx.doi.org/10.2807/1560-7917.ES.2017.22.13.30494CrossRef
|